Sponsor:
Duk-Woo Park, MD
Code:
NCT03826264
Conditions
Heart Valve Diseases
Aortic Valve Insufficiency
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
TAVR
Brief summary:
Conditions
Heart Valve Diseases
Aortic Valve Insufficiency
Study ID
NCT03826264
Start date
Jun 15, 2019
Status verified date
Dec, 2025
Completion date
Dec 31, 2036
Anticipated
Primary completion date
Dec 31, 2035
Anticipated
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Enrollment
10000 participants
Anticipated
Arms
Korea Centers
Stanford University
Northwestern University
Cheng-Hsin Hospital
Interventions
TAVR
Primary outcome measure
Central contacts
Do-yoon Kang, MD
kdy1218@gmail.comLocations
Stanford University
Recruiting
Stanford, California, United States, 94305
Principal Investigator:
Alan Ching Yuenn Yeung, MD
Northwestern Memorial Hospital
Recruiting
Chicago, Illinois, United States, 60611
Principal Investigator:
James D. Flaherty, MD
Sponsor
Duk-Woo Park, MD
Last update posted
Jan 2, 2026
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Duk-Woo Park, MD on 2026-01-02.